Participating Faculty

Strategies for Improving Outcomes in the Management of Epilepsy: Clinician and Payer Perspectives

Part I

This supplement to The American Journal of Managed Care reviews the clinical and economic burden of epilepsy for patients and healthcare payers. It is the first in a series of publications which will educate and inform managed care practitioners and decision makers about opportunities to improve outcomes in the management of patients with epilepsy.

Faculty

William J. Cardarelli, PharmD

Director of Pharmacy

Atrius Health

Harvard Vanguard Medical Associates

Watertown, Massachusetts

Brien J. Smith, MD, FAAN

Medical Director, Comprehensive Epilepsy Program

Henry Ford Hospital

Detroit, Michigan

Faculty Disclosures

These faculty have disclosed the following relevant commercial financial relationships or affiliations in the past 12 months.

Brien J. Smith, MD, FAAN

Board membership: Epilepsy Foundation

Consultant/Advisory Board: Lundbeck, UCB, Inc.

Grants: UCB Inc, Pfizer, NeuroPace

Honoraria/Lecturer: Lundbeck, UCB, Inc.

William J. Cardarelli, PharmD, has nothing to disclose.

Strategies for Improving Outcomes in the Management of Epilepsy: Clinician and Payer Perspectives

Part I

This supplement was supported by UCB, Inc.

The contents of this supplement may include information regarding the use of products that may be inconsistent with or outside the approved labeling for these products in the United States. Physicians should note that the use of these products outside current approved labeling is considered experimental and are advised to consult prescribing information for these products.

Download PDF: Participating Faculty